Original Research

Published on 07 Aug 2020

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling

in Pharmacology of Anti-Cancer Drugs

Jui-Ling Hsu
Wohn-Jenn Leu
Lih-Ching Hsu
Chen-Hsun Ho
Shih-Ping Liu
Jih-Hwa Guh

Frontiers in Oncology

doi 10.3389/fonc.2020.01274

5,104 views
18 citations

Review

Published on 07 Aug 2020

Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity

in Pharmacology of Anti-Cancer Drugs

Xing Huang
Xiaozhen Zhang
Jian Xu
Xun Wang
Gang Zhang
Tianyu Tang
Xiaochao Shen
Tingbo Liang
Xueli Bai

Frontiers in Oncology

doi 10.3389/fonc.2020.01289

5,802 views
6 citations

Review

Published on 05 Aug 2020

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges

in Pharmacology of Anti-Cancer Drugs

De-Hua Yu
Zhi-Yuan Xu
Shaowei Mo
Li Yuan
Xiang-Dong Cheng
Jiang-Jiang Qin

Frontiers in Oncology

doi 10.3389/fonc.2020.01389

10,828 views
28 citations

Original Research

Published on 31 Jul 2020

Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing

in Pharmacology of Anti-Cancer Drugs

Zhihua Xu
Guanzhuang Gao
Fei Liu
Ye Han
Chen Dai
Sentai Wang
Guobang Wei
Yuting Kuang
Daiwei Wan
Qiaoming Zhi

Frontiers in Oncology

doi 10.3389/fonc.2020.01282

3,417 views
2 citations

Original Research

Published on 29 Jul 2020

Knockdown of CYP24A1 Aggravates 1α,25(OH)2D3-Inhibited Migration and Invasion of Mouse Ovarian Epithelial Cells by Suppressing EMT

in Pharmacology of Anti-Cancer Drugs

Ping Wang
Jiming Xu
Weijing You
Yongfeng Hou
Shuiliang Wang
Yujie Ma
Jianming Tan
Zengli Zhang
Wentao Hu
Bingyan Li

Frontiers in Oncology

doi 10.3389/fonc.2020.01258

2,552 views
7 citations

Original Research

Published on 24 Jul 2020

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

in Pharmacology of Anti-Cancer Drugs

Filip Pazdirek
Marek Minarik
Lucie Benesova
Tereza Halkova
Barbora Belsanova
Milan Macek
Lubomír Stepanek
Jiri Hoch

Frontiers in Oncology

doi 10.3389/fonc.2020.01028

4,420 views
30 citations

Original Research

Published on 23 Jul 2020

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance

in Pharmacology of Anti-Cancer Drugs

Meng Zhang
Xuan-Yu Chen
Xing-Duo Dong
Jing-Quan Wang
Weiguo Feng
Qiu-Xu Teng
Qingbin Cui
Jing Li
Xiang-Qi Li
Zhe-Sheng Chen

Frontiers in Oncology

doi 10.3389/fonc.2020.01219

3,585 views
21 citations

Original Research

Published on 16 Jul 2020

NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer

in Pharmacology of Anti-Cancer Drugs

Tao Qin
Liang Cheng
Ying Xiao
Weikun Qian
Jie Li
Zheng Wu
Zheng Wang
Qinhong Xu
Wanxing Duan
Lucas Wong

Frontiers in Oncology

doi 10.3389/fonc.2020.01038

5,434 views
37 citations

Case Report

Published on 10 Jul 2020

Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option

in Pharmacology of Anti-Cancer Drugs

Hyun Yang
Pil Soo Sung
Eun Sun Jung
Sungwoo Cho
Si Hyun Bae
Dong-Wook Kim

Frontiers in Oncology

doi 10.3389/fonc.2020.01160

4,045 views
4 citations

Original Research

Published on 02 Jul 2020

Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas

in Pharmacology of Anti-Cancer Drugs

Saisai Tian
Rui Jing
Weidong Zhang

Frontiers in Oncology

doi 10.3389/fonc.2020.01001

3,815 views
5 citations

Original Research

Published on 30 Jun 2020

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

in Pharmacology of Anti-Cancer Drugs

Letitia-Elena Radu
Andrei Colita
Sergiu Pasca
Ciprian Tomuleasa
Codruta Popa
Catalin Serban
Anca Gheorghe
Andreea Serbanica
Cristina Jercan
Andra Marcu

Frontiers in Oncology

doi 10.3389/fonc.2020.00923

8,925 views
15 citations

Review

Published on 29 Jun 2020

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?

in Pharmacology of Anti-Cancer Drugs

Cristina Turcas
Vlad Moisoiu
Andrei Stefancu
Ancuta Jurj
Stefania D. Iancu
Patric Teodorescu
Sergiu Pasca
Anca Bojan
Adrian Trifa
Sabina Iluta

Frontiers in Oncology

doi 10.3389/fonc.2020.01024

6,066 views
4 citations

Original Research

Published on 25 Jun 2020

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Weiguo Feng
Meng Zhang
Zhuo-Xun Wu
Jing-Quan Wang
Xing-Duo Dong
Yuqi Yang
Qiu-Xu Teng
Xuan-Yu Chen
Qingbin Cui
Dong-Hua Yang

Frontiers in Oncology

doi 10.3389/fonc.2020.00955

5,447 views
39 citations

Original Research

Published on 24 Jun 2020

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma

in Pharmacology of Anti-Cancer Drugs

Weiwei Shi
Shan Zhang
Ding Ma
Dongliang Yan
Guang Zhang
Yin Cao
Zhongxia Wang
Junhua Wu
Chunping Jiang

Frontiers in Oncology

doi 10.3389/fonc.2020.00694

5,749 views
34 citations

Original Research

Published on 12 Jun 2020

Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells

in Pharmacology of Anti-Cancer Drugs

Li Yang
Xin Chen
Qianqian Yang
Jinghong Chen
Qingtian Huang
Leyi Yao
Ding Yan
Jiawen Wu
Peiquan Zhang
Daolin Tang

Frontiers in Oncology

doi 10.3389/fonc.2020.00949

8,366 views
77 citations

Mini Review

Published on 02 Jun 2020

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance

in Pharmacology of Anti-Cancer Drugs

Yena Cho
Yong Kee Kim

Frontiers in Oncology

doi 10.3389/fonc.2020.00764

9,863 views
87 citations

Navigation group

Articles

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling

Deubiquitinating Enzyme: A Potential Secondary Checkpoint of Cancer Immunity

Targeting MDMX for Cancer Therapy: Rationale, Strategies, and Challenges

Molecular Screening for Nigericin Treatment in Pancreatic Cancer by High-Throughput RNA Sequencing

Knockdown of CYP24A1 Aggravates 1α,25(OH)2D3-Inhibited Migration and Invasion of Mouse Ovarian Epithelial Cells by Suppressing EMT

Monitoring of Early Changes of Circulating Tumor DNA in the Plasma of Rectal Cancer Patients Receiving Neoadjuvant Concomitant Chemoradiotherapy: Evaluation for Prognosis and Prediction of Therapeutic Response

NVP-CGM097, an HDM2 Inhibitor, Antagonizes ATP-Binding Cassette Subfamily B Member 1-Mediated Drug Resistance

NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer

Nilotinib-Induced Immune-Mediated Liver Injury: Corticosteroid as a Possible Therapeutic Option

Network-Based Approach to Identify the Antiproliferative Mechanisms of Bruceine D in Breast Cancer From the Cancer Genome Atlas

Day 15 and Day 33 Minimal Residual Disease Assessment for Acute Lymphoblastic Leukemia Patients Treated According to the BFM ALL IC 2009 Protocol: Single-Center Experience of 133 Cases

SERS-Based Assessment of MRD in Acute Promyelocytic Leukemia?

Erdafitinib Antagonizes ABCB1-Mediated Multidrug Resistance in Cancer Cells

Targeting SphK2 Reverses Acquired Resistance of Regorafenib in Hepatocellular Carcinoma

Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells

Cancer Stem Cells as a Potential Target to Overcome Multidrug Resistance